{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T15:24:01Z","timestamp":1789226641680,"version":"build-2803163510"},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,6,1]]},"DOI":"10.2169\/internalmedicine.0091-22","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T22:20:26Z","timestamp":1666131626000},"page":"1599-1602","source":"Crossref","is-referenced-by-count":3,"title":["Practice of Hereditary ATTR Amyloidosis in Non-endemic Areas of Japan"],"prefix":"10.2169","volume":"62","author":[{"given":"Masaaki","family":"Matsushima","sequence":"first","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monami","family":"Tarisawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"},{"name":"Department of Neurology, Obihiro Kosei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"},{"name":"Department of Neurology, Japanese Red Cross Asahikawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Oshima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"},{"name":"Department of Neurology, Japanese Red Cross Asahikawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanao","family":"Yoshino","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"},{"name":"Department of Neurology, Obihiro Kosei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Shibata","sequence":"additional","affiliation":[{"name":"Division of Clinical Genetics, Hokkaido university Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Wakita","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Shirai","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yaguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Yabe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Plante-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol 10: 1086-1097, 2011.","DOI":"10.1016\/S1474-4422(11)70246-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 62: 1057-1062, 2005.","DOI":"10.1001\/archneur.62.7.1057"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ando Y, Yamashita T, Misumi Y, et al. Clinical, pathological, and proteomic characteristics of newly diagnosed amyloidosis patients: experience from a single referral center in Japan. Neurol Clin Neurosci 9: 37-44, 2021.","DOI":"10.1111\/ncn3.12384"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Koike H, Tanaka F, Hashimoto R, et al. Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas. J Neurol Neurosurg Psychiatry 83: 152-158, 2012.","DOI":"10.1136\/jnnp-2011-301299"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Coelho T, Maia LF, da Silva AM, et al. Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. J Neurol 260: 2802-2814, 2013.","DOI":"10.1007\/s00415-013-7051-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Coelho T, Adams D, Silva A, et al. Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med 369: 819-829, 2013.","DOI":"10.1056\/NEJMoa1208760"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Vinik EJ, Hayes RP, Oglesby A, et al. The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther 7: 497-508, 2005.","DOI":"10.1089\/dia.2005.7.497"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kato-Motozaki Y, Ono K, Shima K, et al. Epidemiology of familial amyloid polyneuropathy in Japan: identification of a novel endemic focus. J Neurol Sci 270: 133-140, 2008.","DOI":"10.1016\/j.jns.2008.02.019"},{"key":"9","unstructured":"9. Adams D, Polydefkis M, Gonz\u00e1lez-Duarte A, et al. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Lancet Neurol 20: 49-59, 2021."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gentile L, Russo M, Luigetti M, et al. Patisiran in hATTR amyloidosis: six-month latency period before efficacy. Brain Sci 11: 515, 2021.","DOI":"10.3390\/brainsci11040515"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Koike H, Hashimoto R, Tomita M, et al. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Amyloid 18: 53-62, 2011.","DOI":"10.3109\/13506129.2011.565524"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sekijima Y, Ueda M, Koike H, Misawa S, Ishii T, Ando Y. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Orphanet J Rare Dis 13: 6, 2018.","DOI":"10.1186\/s13023-017-0726-x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/11\/62_0091-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:32:21Z","timestamp":1715315541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/11\/62_0091-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0091-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"article-number":"0091-22"}}